Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,764 | -46,664 | -170,370 | -123,132 | -74,911 |
| Depreciation Amortization | 4,642 | -173 | -5,291 | -4,687 | -3,570 |
| Accounts payable and accrued liabilities | 1,565 | 6,156 | -2,747 | -7,569 | -6,774 |
| Other Working Capital | -11,754 | 2,039 | -12,669 | -9,527 | -12,761 |
| Other Operating Activity | -42,834 | -79 | 19,811 | 21,963 | 11,231 |
| Operating Cash Flow | $-78,145 | $-38,721 | $-171,266 | $-122,952 | $-86,785 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 84,306 | 41,606 | 149,293 | 83,281 | 66,267 |
| PPE Investments | N/A | N/A | -79 | -79 | -79 |
| Sale Of Investment | N/A | N/A | 7,144 | N/A | N/A |
| Investing Cash Flow | $84,306 | $41,606 | $156,358 | $83,202 | $66,188 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 512 | 512 | 6,425 | 2,470 | 598 |
| Other Financing Activity | -3,144 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-2,632 | $512 | $6,425 | $2,470 | $598 |
| Exchange Rate Effect | -113 | -101 | 141 | 139 | 234 |
| Beginning Cash Position | 37,732 | 37,732 | 46,074 | 46,074 | 46,074 |
| End Cash Position | 41,148 | 41,028 | 37,732 | 8,933 | 26,309 |
| Net Cash Flow | $3,416 | $3,296 | $-8,342 | $-37,141 | $-19,765 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,145 | -38,721 | -171,266 | -122,952 | -86,785 |
| Capital Expenditure | 0 | 0 | -79 | -79 | -79 |
| Free Cash Flow | -78,145 | -38,721 | -171,345 | -123,031 | -86,864 |